Meeting
2015 ASCO Annual Meeting
XPC, XPF, TP53 and GSTP1 polymorphisms in prognosis of cutaneous melanoma patients.
Authors
Carmen Silvia Passos Lima
Department of Internal Medicine, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil
Carmen Silvia Passos Lima , Gabriela Vilas Boas Gomez , Cristiane Oliveira , Gustavo Jacob Lourenco , José Augusto Rinck Jr., Aparecida Machado Moraes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Melanoma/Skin Cancers
Citation
J Clin Oncol 33, 2015 (suppl; abstr 9038)
DOI
10.1200/jco.2015.33.15_suppl.9038
Abstract #
9038
Poster Bd #
281
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Genome-wide association study to reveal novel germline markers of melanoma survival.
First Author: Vylyny Chat
Poster
2021 ASCO Annual Meeting
The prognostic impact of RAS and TP53 mutation according to primary tumor location in colorectal liver metastases.
First Author: Yongjun Cha
Poster
2021 Gastrointestinal Cancers Symposium
Serial cell-free DNA (cfDNA) sampling in advanced pancreatic ductal adenocarcinoma (PDAC) patients may predict therapeutic outcome.
First Author: Gehan Botrus
Poster
2020 Gastrointestinal Cancers Symposium
Distinct clinical characteristics of young-onset pancreatic cancer patients.
First Author: Suleyman Yasin Goksu